Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina

Author： Robiolo B.   Grigera P.R.   Periolo O.H.   Seki C.   Bianchi T.   Maradei E.   La Torre J.L.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.14, 1995-10, pp. : 1346-1352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach

By Barnett P.V.   Statham R.J.   Vosloo W.   Haydon D.T.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3240-3248

Elsevier

Access to resources Recommend Favorite

Potency test of inactivated Newcastle disease vaccines by monoclonal antibody blocking ELISA

By Horvath E.   Czifra G.   Nagy E.   Engstrom B.   Merza M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2969-2973

Elsevier

Access to resources Recommend Favorite

Efficacy of foot-and-mouth disease vaccine in pigs with single dose immunization

By Liao P.C.   Lin Y.L.   Jong M.H.   Chung W.B.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1807-1810

Elsevier

Access to resources Recommend Favorite

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

By Wang C.Y.   Chang T.Y.   Walfield A.M.   Ye J.   Shen M.   Chen S.P.   Li M.C.   Lin Y.L.   Jong M.H.   Yang P.C.   Chyr N.   Kramer E.   Brown F.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2603-2610

Elsevier

Access to resources Recommend Favorite

International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants

By Barnett P.V.   Pullen L.   Williams L.   Doel T.R.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1187-1198

Elsevier

Access to resources Recommend Favorite